Literature DB >> 2177717

Transcriptional activation by the pseudorabies virus immediate early protein.

K J Martin1, J W Lillie, M R Green.   

Abstract

The pseudorabies virus immediate early (IE) protein is a potent, promiscuous activator of viral and cellular gene transcription. The promiscuous action of IE protein has led to the suggestion that it functions by an unusual mechanism. Here, we show that IE protein has the two essential features of a typical cellular activator: (1) a transcriptional activation region, and (2) a separable region that directs IE protein, or an unrelated activation region, to the vicinity of the promoter. We map the IE protein activation region to 34 amino acids, demonstrate that it is comparable in strength to the strongest known activation region, and show that it is required for the transcriptional activity of the intact IE protein. The 34-amino-acid IE protein activation region is highly acidic. We provide evidence that it uses the same cellular target as an unrelated acidic activator and a different target from that of a nonacidic activator. Our results provide insight into the function of promiscuous eukaryotic transcriptional activators.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177717     DOI: 10.1101/gad.4.12b.2376

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  22 in total

1.  Identification of a motif in the C terminus of herpes simplex virus regulatory protein ICP4 that contributes to activation of transcription.

Authors:  James W Bruce; Kent W Wilcox
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  The VP16 paradox: herpes simplex virus VP16 contains a long-range activation domain but within the natural multiprotein complex activates only from promoter-proximal positions.

Authors:  M Hagmann; O Georgiev; W Schaffner
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Molecular cloning and characterization of additional factors that bind to the interferon-alpha/beta response element B of the murine (2'-5')oligoadenylate synthetase ME-12 gene.

Authors:  C Yan; I Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

4.  The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID.

Authors:  C Hagemeier; S Walker; R Caswell; T Kouzarides; J Sinclair
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.

Authors:  J M Pongubala; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

6.  Identification of a promoter-specific transactivation domain in the herpes simplex virus regulatory protein ICP4.

Authors:  W Xiao; L I Pizer; K W Wilcox
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 7.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

8.  Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation.

Authors:  H Ge; Y Si; R G Roeder
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

9.  Functional domains of the simian foamy virus type 1 transcriptional transactivator (Taf).

Authors:  A Mergia; L W Renshaw-Gegg; M W Stout; R Renne; O Herchenröeder
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  A TEF-1-element is required for activation of the promoter of pseudorabies virus glycoprotein X gene by IE180.

Authors:  Chia-Jen Ou; Min-Liang Wong; Tien-Jye Chang
Journal:  Virus Genes       Date:  2002-12       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.